NORWALK, Conn.,
Sept. 1, 2020 /PRNewswire/
-- TriRx Pharmaceutical Services, a global contract
development and manufacturing organization (CDMO) serving the
biopharmaceutical market, today announced that it has finalized an
agreement with MSD Sante Animale, a division of Merck & Co.,
Inc., Kenilworth, N.J., USA
(NYSE:MRK), to acquire the operations and ownership of their
manufacturing site located in Segré, France.
Timothy C. Tyson, Chairman &
CEO of TriRx stated, "We are excited to welcome the Segre team to
the TriRx family and to partner with MSD Animal Health to continue
to provide important products to the market. This transaction
allows us to continue our expansion as a global CDMO while assuring
continuity of supply of animal health products from the Segré site.
The site's history of exceptional performance and the world class
knowledge and experience of the site staff expand TriRx service
offerings into sterile suspensions and liquids and non-sterile
ointments and liquids." The site currently manufactures a range of
veterinary products and has over ninety employees.
The state-of-the-art integrated facility has dedicated office,
production, sampling and warehouse areas and delivers products to
all major global markets. The agreement has officially been
executed today with all customary regulatory, regional and local
approvals. "This site will transition to a worldwide center of
contract manufacturing excellence in the fast growing, animal
health market", said Tyson. "And will continue to be a significant
contributor to the local economy", Tyson added.
About TriRx
TriRx Pharmaceutical Services is a global contract development
and manufacturing organization (CDMO) serving the biopharmaceutical
market. Headquartered approximately 50 miles outside of
New York City in Norwalk, Connecticut, TriRx operates
facilities providing state-of-the-art laboratory, manufacturing,
packaging and warehousing capabilities. Visit www.trirx.com.
For further information:
Name Jeremy R Tatum, VP Sales
Email jrtatum@trirx.com
Tel 256-714-1839
View original content to download
multimedia:http://www.prnewswire.com/news-releases/trirx-pharmaceutical-services-acquires-msd-animal-health-manufacturing-site-located-in-segre-en-anjou-bleu-france-including-long-term-supply-agreement-301120783.html
SOURCE TriRx Pharmaceutical Services